EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Anti-VEGF therapy - a new hope in AMD treatment

Ana-Maria Stoica, Sanda Jurja, Nejla Dervis

romanian journal of ophthalmology · 2025

DOI: 10.22336/rjo.2025.52 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift romanian journal of ophthalmology, 2025. Verfasst von Ana-Maria Stoica und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, "Sf. Apostol Andrei" County Emergency Clinical Hospital, Constanţa, Romania. Hauptthemen laut MEDLINE: Vascular Endothelial Growth Factor A, Angiogenesis Inhibitors, Choroidal Neovascularization, Macular Degeneration. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Choroidal neovascularization (CNV) secondary to age-related macular degeneration (AMD) represents a significant global cause of visual impairment. Contemporary therapeutic approaches for neovascular AMD focus on inducing regression of CNV by inhibiting critical growth factors involved in angiogenesis. For nearly two decades, vascular endothelial growth factor (VEGF) has been the principal therapeutic target, with multiple intravitreally administered agents developed to achieve anatomical restoration and improved visual outcomes through sustained dosing.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Vascular Endothelial Growth Factor AAngiogenesis InhibitorsChoroidal NeovascularizationMacular DegenerationWet Macular DegenerationHumansIntravitreal InjectionsRanibizumabBevacizumab

Stichwörter der Autor:innen

AMD = age-related macular degenerationBCVA = best-corrected visual acuityCNV = choroidal neovascularizationDARPins = designed ankyrin repeat proteinsPDT = photodynamic therapyPEDF = pigment epithelium–derived factorPIGF = placental growth factorRPE = the retinal pigment epitheliumVEGF = vascular endothelial growth factoranti-VEGFgene therapyneovascular AMDretina

Substanzen

Vascular Endothelial Growth Factor AAngiogenesis InhibitorsRanibizumabVEGFA protein, humanBevacizumab

Autor:innen und Institutionen

  • Department of Ophthalmology, "Sf. Apostol Andrei" County Emergency Clinical Hospital, Constanţa, Romania.
  • Department of Ophthalmology, General Medicine Faculty, Ovidius University, Constanţa, Romania.
  • Department of Diabetes, "Sf. Apostol Andrei" County Emergency Clinical Hospital, Constanţa, Romania.

Zitieren

APA

Stoica, A. M., Jurja, S., & Dervis, N. (2025). Anti-VEGF therapy - a new hope in AMD treatment. romanian journal of ophthalmology. https://doi.org/10.22336/rjo.2025.52

Vancouver

Stoica AM, Jurja S, Dervis N. Anti-VEGF therapy - a new hope in AMD treatment. romanian journal of ophthalmology. 2025. doi:10.22336/rjo.2025.52

BibTeX
@article{Stoica2025,
  author = {Stoica, Ana-Maria and Jurja, Sanda and Dervis, Nejla},
  title = {Anti-VEGF therapy - a new hope in AMD treatment},
  journal = {romanian journal of ophthalmology},
  year = {2025},
  doi = {10.22336/rjo.2025.52}
}
Kostenlos starten →